Can I read Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses on EtoBox?

Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses by Luigi de Luca; Nicola Vitale; Bruno Giannolo; Giuseppe Cafarella; Luigi Piazza; Maurizio Cotrufo is a Medicine article available to read on EtoBox.

What is Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses about?

## Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses The CarboMedics cardiac prosthesis (CarboMedics, Inc., Austin, Tex.) is a relatively new, low-profile bileaftet prosthesis. We report the results of a prospective mid-term evaluation of 426 CarboMedics prostheses implanted at our institution. Three hundred fifty patients had CarboMedics prostheses implanted in the mitral (n = 125), aortic (n = 149), or aortic and mitral positions (n = 76). Hospital mortality was 5.2 %. Follow-up was 98 % complete, with 478 patient/years and a mean follow-up of 19 months (range 1 to 42 months). Actuarial freedom from complications were calculated as follows (linearized rates in parentheses): late mortality 97% ± 0.77% (2.7%), thromboembolism 98% ± 0.4 % (0.5 %\ anticoagulation-related hemorrhage 98.6 % ± 0.4 % (0.4%), nonstructural dysfunction 98.5% ± 0.6 (0.2%), valve-related mortality 91.5% ± 0.7 (0.5%), valve failure 90.9% ± 1 % (0.7%), treatment failure 92.8 % ± 0.8 % (0.7 %), and all valve-related morbidity and mortality 90 % ± 2 % (2.6 %). According to our results, the CarboMedics valve has a low rate of complications that further improves the quality of

Who reads Mid-term follow-up after heart valve replacement with CarboMedics bileaflet prostheses?

Author

Luigi de Luca; Nicola Vitale; Bruno Giannolo; Giuseppe Cafarella; Luigi Piazza; Maurizio Cotrufo

Publisher

CTSNet; American Association for Thoracic Surgery; Mosby Inc.; Elsevier BV; Publons (ISSN 1097-685X)

Published

1993

Language

EN

Field

Medicine (Health Sciences)